Tag Archives: Antibiotic

29Oct/26

Why STIs Are Outsmarting Modern Medicine

Surging Cases and Superbug Strains: Inside Europe’s Escalating Sexual Health Crisis

Thu, July 29 2026 /Mpelembe Media/ — Bacterial sexually transmitted infections have reached record highs across Europe, led by a surge in gonorrhoea notifications that reached 106,331 cases in 2024—a 303% increase since 2015 and the highest level recorded since European surveillance began. Over the same decade, syphilis cases more than doubled to 45,577, while congenital syphilis cases nearly doubled in a single year to 140. Although men who have sex with men account for the majority of diagnoses (62% of gonorrhoea cases), infections are increasingly expanding into heterosexual populations and young adults, particularly women aged 20 to 24. Epidemiologists attribute this multi-pathogen resurgence to a complex interplay of post-pandemic behavioural shifts, declining condom usage, expanded HIV PrEP protocols that mandate routine screening and catch more asymptomatic cases, and structural healthcare barriers such as out-of-pocket testing fees required in 13 European countries. Continue reading →

20Nov/25

Antibiotics: Falling Prices, Rising Costs, and Shortages in Europe

Findings from a European study highlights the critical economic challenges facing the production of essential off-patent antibiotics, particularly in the context of rising antimicrobial resistance (AMR). Viatris and Medicines for Europe sponsored the independent study, which revealed that between 2020 and 2024, the average price of top-selling off-patent antibiotics dropped by over 10%, while industrial costs such as energy, labour, and overall production surged significantly. This unsustainable dynamic has led to antibiotic shortages and market withdrawals, ultimately threatening patient access across Europe. The organisations urgently call for policy reform, including price indexation, minimum price policies, and procurement changes, to secure the economic viability and long-term availability of these vital medicines and combat the growing threat of AMR. Continue reading